Promotional banner for The Value of Scaling: PSC Suspension Cultures infographic

Hospitals that adopt in-house testing greatly reduce turnaround times from biopsy to report. In this in-depth webinar, you will hear how one facility went from a median turnaround time of 64 days to just 4 days. They also found that when testing was brought in house, 94% of oncologists had biomarker data available at the time of patient consult, compared to only 17% prior.

Brandon Sheffield, MD, FRCPC

Brandon Sheffield, MD, FRCPC

Dr. Sheffield is an anatomic and molecular pathologist. He is currently serving as the Medical Director of Immunohistochemistry and Molecular Pathology and the Physician Lead of Research for the William Osler Health System in Canada. Dr. Sheffield focuses on the delivery of personalized medicine and precision oncology and making molecular testing available to community cancer patients in Canada.

Parneet Cheema

Parneet Cheema, HBSC, MD, BIOTECH, FRCPC

Dr. Cheema is an Assistant Professor at the University of Toronto and Head of Medical Oncology/Hematology and Cancer Research at William Osler. She is an internationally known expert in lung cancer and precision cancer care and has conducted numerous clinical trials and published national consensus statements. Her research focuses on lung cancer treatment and immunotherapy and safely and efficiently turning advancements in personalized medicine into day-to-day clinical practice. She founded the William Osler Cancer Immunotherapy Program and has worked closely with her pathology colleagues to develop cancer genomics at William Osler.

*
*
*
*
*
*
*

Please indicate below if you would like to discuss NGS options on an individualized basis after viewing the webinar with one of our commercial team members. You may still access the webinar if you don’t click below.

 I would like to be contacted by a commercial team member

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.